M&A
3i to invest €181m in German car parts maker Schlemmer in buyout
Private equity group 3i said it had agreed to invest €181m in German car parts maker Schlemmer as part of a buyout.
Jazz Pharmaceuticals to buy Celator for $1.5bn
Jazz Pharmaceuticals has agreed to buy Celator Pharmaceuticals for $30. 25 per share in cash, or around $1. 5bn, which will be financed with a combination of cash on hand and borrowings under its senior secured credit facility.
Darty board recommends investors accept Fnac offer
FTSE 250 electrical goods retailer Darty said on Tuesday that its board has recommended shareholders approve a 170p-per-share takeover offer from French retailer Fnac.
Lloyds eyes bid for Bank of America's UK credit-card business - report
Lloyds Banking Group is preparing to bid for Bank of America’s UK credit-card business, MBNA, in what may be its first acquisition since being rescued by taxpayers in 2009, according to a media report.
Thermo Fisher to buy FEI in $4.2bn deal
Thermo Fisher Scientific has agreed to buy lab equipment company FEI for $107. 50 per share in cash, or around $4. 2bn.
Shire shareholders approve Baxalta merger
Shire’s shareholders have approved the company’s $32bn merger with US-based Baxalta Inc.
Marshall Motors sees significant value in Ridgeway acquisition
Marshall Motor Holdings' shares are up more than 20% after it acquired Ridgeway Garages (Newbury) Ltd for £106. 9m cash.
Takata surges on KKR buyout reports
Shares in Japan’s Takata Corp surged on Thursday following a report that US private equity firm Kohlberg Kravis Roberts is looking to buy a 60% stake in the auto parts maker.
Canada's WSP to buy Sweett Group for £24m
AIM-listed Sweett Group, which provides professional services for the construction and management of building and infrastructure projects, has agreed to be bought by Canada’s WSP Global Inc for around £24m.
Monsanto said to reject Bayer offer as it seeks higher price
US agriculture giant Monsanto is reportedly set to reject German chemical and pharmaceutical company Bayer’s acquisition bid and seek a higher price.
Shanks confirms talks to acquire Van Gansewinkel in reverse takeover
Shanks said it is on the verge of making an acquisitive approach for a larger rival, Dutch and Belgian waste collection and recycling business Van Gansewinkel, which would constitute a reverse takeover.
LendingClub's shares rise as Shanda Group acquires stake
Singapore-based investment company Shanda Group has acquired an 11. 7% stake in under-pressure LendingClub, pushing the beleaguered shares up more than 8% today.
Monsanto likely to reject Bayer approach as BASF looks on, Olivetree says
Monsanto is likely to reject the takeover approach from Germany's Bayer, analysts at Olivetree Financial suggested on Monday, although the price of the deal is "hard to argue against".
Glenwick suspends shares ahead of expected reverse takeover deal
Cash shell Glenwick has suspended trading of its shares as it nears its much-anticipated reverse takeover in the natural resources sector.
Bayer offers USD63bn for Monsanto
German drugs and chemicals giant Bayer has made a €55bn (£43bn) all-cash offer for US agricultural science group Monsanto.
The Restaurant Group attracting private equity interest, reports say
Shares in The Restaurant Group spiked on Thursday afternoon as reports emerged of possible private equity interest in the lately troubled Garfunkel's and Frankie & Benny's owner.
Bayer confirms takeover talks with Monsanto
Shares in Bayer tumbled on Thursday after the German pharmaceuticals group confirmed it was in takeover talks with US seed giant Monsanto.
Gannett raises bid price for rival Tribune, offers 99% premium
Publishing group Gannett upped the ante in its bid to acquire rival Tribune Publishing Company, raising the amount of its all-cash offer for the entire company by 22. 4% to $15. 00 per share.
Pfizer to splash USD5.2bn cash on eczma group Anacor
Pfizer has agreed to acquire Nasdaq-listed Anacor for $5. 2bn cash ahead of potential regulatory approval for its crisaborole dermatitis treatment.
Nissan confirms plans to take 34% stake in scandal-hit Mitsubishi
Japanese auto colossus Nissan has agreed to pay 237bn yen (£1. 5bn) for a third of rival Mitsubishi Motors, which is reeling from admissions it falsified fuel economy data.